Minoxidil: a review of its pharmacological properties and therapeutic use.

scientific article published on October 1981

Minoxidil: a review of its pharmacological properties and therapeutic use. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1037127203
P356DOI10.2165/00003495-198122040-00001
P698PubMed publication ID7030707

P2093author name stringV M Campese
P2860cites workNeed for beta-blockade in hypertension reduced with long-term minoxidilQ28317132
Acute cardiomyopathy induced by the vasodilating antihypertensive agent minoxidilQ28326717
Hypertrichosis due to minoxidilQ28328717
Clinical and haemodynamic effects of minoxidil in refractory hypertensionQ28328983
Metabolism of minoxidil, a new hypotensive agent II: biotransformation following oral administration to rats, dogs, and monkeysQ28329655
Long-term treatment of severe hypertension with minoxidil, propranolol and furosemideQ28339392
Minoxidil in severe hypertension: value when conventional drugs have failedQ28339588
Minoxidil-induced hypertrichosis: treatment with calcium thioglycolate depilatoryQ34366321
Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activityQ34473162
Hypertrichosis lanuginosa associated with diazoxide therapy in prepubertal children: a clinicopathologic studyQ34702102
Long-term treatment of severe hypertension with minoxidilQ35817735
Treatment of severe hypertension with minoxidilQ39064011
Clonidine and the vasodilating beta blocker antihypertensive drug interactionQ39154966
Minoxidil in Severe HypertensionQ39183865
Minoxidil in refractory hypertension. Effects on blood pressure, plasma volume and muscle blood flowQ39241599
Double-Blind Comparison of Minoxidil and Hydrallazine in Severe HypertensionQ39811101
The pharmacologic basis of antihypertensive therapy: The role of vasodilator drugsQ39874716
Pharmacology and Pharmacokinetics of MinoxidilQ40098145
[Clinical experiences with minoxidil, a new antihypertensive agent]Q68884775
Pharmacologic properties of minoxidil: a new hypotensive agentQ69381505
Minoxidil in severe hypertension with renal failure. Effect of its addition to conventional antihypertensive drugsQ69481858
Bilateral nephrectomy for control of hypertension in uremiaQ69863610
HirsutismQ69878772
Mechanisms of autonomic nervous system dysfunction in uremiaQ70183489
Pharmacokinetic studies of minoxidilQ70374165
Myocardial papillary muscle necrosis induced by hypotensive agents in dogsQ70635125
Renal function during long-term treatment of hypertension with minoxidil: comparison of benign and malignant hypertensionQ70716937
Minoxidil: right atrial cardiac pathology in animals and in manQ71263093
Plasma Renin Activity and Blood Pressure in Terminal Renal FailureQ71815735
Uremic pericarditis. Clinical features and managementQ72096635
Treatment of Refractory Hypertension with MinoxidilQ72612354
Minoxidil in the treatment of refractory hypertension due to a spectrum of causesQ72612362
Efficacy of minoxidil in the treatment of severe hypertension in systemic disordersQ72612365
Long-Term Treatment With Minoxidil in Patients With Severe Renal FailureQ72612367
Clinical Response of Hypertensive Children to Long-Term Minoxidil TherapyQ72612369
Rapid reduction of severe hypertension with minoxidilQ72612371
Serial Electrocardiographic Changes During Long-Term Treatment of Server Hypertension with MinoxidilQ72612374
Pericardial Disorders Occurring During Open-Label Study of 1,869 Severely Hypertensive Patients Treated with MinoxidilQ72612378
Minoxidil in the Management of Moderate HypertensionQ72612384
Circulatory studies in hypertensive patients at rest and during exercise, with a note on the Starling relationship in the left ventricle in essential hypertensionQ74489542
Bilateral nephrectomy for malignant hypertensionQ93721209
Minoxidil and the treatment of severe hypertensionQ40290314
Captopril: a preliminary review of its pharmacological properties and therapeutic efficacyQ40300185
Altered renin release and propranolol potentiation of vasodilatory drug hypotensionQ40317304
Minoxidil--haemodynamic and clinical experiences with a new peripheral vasodilatorQ40329388
The physiological basis of thirstQ40564696
Long-term experiences with minoxidil in combination treatment of severe arterial hypertensionQ40665598
Minoxidil therapy in children with severe hypertensionQ40766284
Effect of minoxidil on blood pressure and hemodynamics in severe hypertensionQ40770064
Long-Term Clinical Effects, Bioavailability, and Kinetics of Minoxidil in Relation to Renal FunctionQ40956673
Minoxidil in severe hypertensionQ40977516
Treatment of Severe Hypertension with Minoxidil: Advantages and LimitationsQ41035180
Vasodilating antihypertensive drug-induced aldosterone release--a study of endogenous angiotensin-mediated aldosterone release in the ratQ41071181
Toxicologic studies with the hypotensive agent minoxidilQ41232877
Rapid blood pressure control with minoxidil: acute and chronic effects on blood pressure, sodium excretion, and the renin-aldosterone systemQ41603963
Renal Function and Vascular Resistance During Long-Term Minoxidil Treatment of Severe HypertensionQ42242755
Long-term effects of minoxidil therapy on renal function of patients with refractory hypertension: the significance of albuminuriaQ42242759
Renal Function in Long-Term Minoxidil-Treated PatientsQ42242761
Rebound hypertension following minoxidil withdrawalQ42271636
Hazards in treatment of systolic hypertensionQ43630522
Comparative splanchnic blood flow effects of various vasodilator compoundsQ43945925
Minoxidil Increases Aldosterone Metabolic Clearance in Hypertensive Patients*Q43995962
Use of Minoxidil in the Azotemic PatientQ44267151
Treatment of severe and moderate hypertension with minoxidil: experience in twenty-eight patientsQ44952074
Renal failure, uncontrollable thirst, and hyperreninemia. Cessation of thirst with bilateral nephrectomyQ48632122
Urgent bilateral nephrectomy for severe hypertensionQ48766574
Drinking induced by injection of angiotensin into the rain of the rat.Q48900874
A central effect of angiotensin: release of pituitary pressor materialQ48910238
Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.Q53829232
Differential effects of propranolol on heart rate and plasma renin activity in patients treated with minoxidil.Q54175978
Unusual Cases of Resistance to Minoxidil TherapyQ54563726
Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses.Q54563730
Minoxidil for severe hypertension after failure of other hypotensive drugs.Q54594123
The effects of minoxidil on pulmonary and systemic hemodynamics in hypertensive man.Q54600664
Minoxidil reduces pulmonary vascular resistance in dogs and cattle.Q54605370
Severe hypertension. Treatment with minoxidil.Q54624274
Tissue distribution and hypotensive effects of minoxidil in normotensive rats.Q54659828
Combined therapy with vasodilator drugs and beta-adrenergic blockade in hypertension. A comparative study of minoxidil and hydralazine.Q55061463
The control of hypertension in patients undergoing regular maintenance hemodialysisQ66844963
Vasodilating drugs: contrasting haemodynamic effectsQ66864186
The use of minoxidil in the treatment of severe essential hypertension: a report on 100 patientsQ66864188
Treatment of severe hypertension with minoxidil and its effects on systemic and pulmonary haemodynamicsQ66864190
Minoxidil Therapy in Refractory Hypertension Analysis of 155 PatientsQ66888516
Pulmonary hemodynamics in systemic hypertension. Long-term effect of minoxidilQ66923022
A method for achieving blood pressure control expeditiously with oral minoxidilQ66956028
Minoxidil therapy for refractory hypertension and chronic renal failureQ66968374
Role of sympathetic nerve inhibition and body sodium-volume state in the antihypertensive action of clonidine in essential hypertensionQ67269234
Long-Term Treatment of Refractory Hypertensive Patients With MinoxidilQ67319333
Effects of minoxidil on coronary collateral flow and acute myocardial injury following experimental coronary artery occlusionQ67325594
The dominance of adrenergic mechanisms in mediating hypotensive drug-induced renin release in the conscious ratQ67469804
Long-term effects of minoxidil in the treatment of malignant hypertension in chronic renal failureQ67493931
Minoxidil treatment of severe hypertensionQ67509692
Increased pulmonary vascular resistance with systemic hypertension. Effect of minoxidil and other antihypertensive agentsQ67584182
Management of severe childhood hypertension with minoxidil: a controlled clinical studyQ67587323
Minoxidil--an alternative to nephrectomy for refractory hypertensionQ68510756
P433issue4
P304page(s)257-278
P577publication date1981-10-01
P1433published inDrugsQ3040094
P1476titleMinoxidil: a review of its pharmacological properties and therapeutic use.
P478volume22

Reverse relations

cites work (P2860)
Q38031524Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney
Q33160283Antipsychotic pharmacotherapy and orthostatic hypotension: identification and management
Q47913024Clinical pharmacokinetics of vasodilators. Part I.
Q34742268Clinical pharmacology of antihypertensive drugs
Q70562523Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension
Q41600656Current clinical pathophysiologic considerations in essential hypertension
Q52560083Diagnosis and management of resistant hypertension: state of the art.
Q38512174Direct Vasodilators and Sympatholytic Agents
Q57023536Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases
Q34708717Drug Prescribing in Renal Failure: Dosing Guidelines for Adults
Q34407512Effect of topically applied minoxidil on the survival of rat dorsal skin flap
Q39548978Guide to drug dosage in renal failure
Q35738465Hypertension and the vascular patient
Q39166266Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension
Q36138286Influence of antihypertensive therapy on renal function
Q69643748Minoxidil analysis in human plasma using high-performance liquid chromatography with electrochemical detection. Application to pharmacokinetic studies
Q68879454Minoxidil and captopril in severe hypertension
Q93184657Minoxidil and its use in hair disorders: a review
Q39720651Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis
Q35046070Minoxidil opens mitochondrial K(ATP) channels and confers cardioprotection
Q72753418Minoxidil sulphation in human liver and platelets. A study of interindividual variability
Q84091149Minoxidil therapy in children and young adult patients with renal disease and refractory hypertension: value when multidrug regimens have failed to achieve blood pressure control
Q87855187Stability of an extemporaneously compounded minoxidil oral suspension
Q41307636The pharmacokinetics of 2.5- to 10-mg oral doses of minoxidil in healthy volunteers
Q37598885Therapeutic applications of drugs acting on peripheral dopamine receptors
Q58282548Three Methods for the Quantitative Determination of Minoxidil
Q49382561Topical Minoxidil Versus Topical Diltiazem for Chemical Sphincterotomy of Chronic Anal Fissure: A Prospective, Randomized, Double-Blind, Clinical Trial.
Q39764424Topical minoxidil. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica
Q35023961Treatment of hypertension from volume to vasoconstriction: The ACE up your sleeve

Search more.